We are live on ! Find out more
AMAG

AMAG Pharmaceuticals
AMAG

Delisted

AMAG was delisted on the 13th of November, 2020.

Back to rankings

174 hedge funds and large institutions have $802M invested in AMAG Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 74 increasing their positions, 58 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 58

6% less funds holding

Funds holding: 185 → 174 (-11)

12% less capital invested

Capital invested by funds: $913M → $802M (-$111M)

38% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 26

70% less call options, than puts

Call options by funds: $4.04M | Put options by funds: $13.4M

Holders
174
Holders Change
-11
Holders Change %
-5.95%
% of All Funds
4.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
74
Reduced
58
Closed
26
Calls
$4.04M
Puts
$13.4M
Net Calls
-$9.37M
Net Calls Change
+$158M

Top Buyers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
+$33.7M
2
Invesco
Invesco
Georgia
+$26.6M
3
Millennium Management
Millennium Management
New York
+$22.8M
4
Citadel Advisors
Citadel Advisors
Florida
+$22.7M
5
Robeco Institutional Asset Management
Robeco Institutional Asset Management
Netherlands
+$6.63M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$12.6M
2
AL
AJO LP
Pennsylvania
-$10.6M
3
NI
Numeric Investors
Massachusetts
-$8.09M
4
Deutsche Bank
Deutsche Bank
Germany
-$7.93M
5
JP Morgan Chase
JP Morgan Chase
New York
-$6.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
76
Swiss National Bank
Switzerland
$1.03M – – –
NFA
77
Nationwide Fund Advisors
Ohio
$968K +$115K +5,800 +12%
Wellington Management Group
78
Wellington Management Group
Massachusetts
$957K -$2.17M -109,702 -68%
LS
79
Livforsakringsbolaget Skandia
Sweden
$912K – – –
Canada Life
80
Canada Life
Manitoba, Canada
$898K +$43.6K +2,200 +5%
Wells Fargo
81
Wells Fargo
California
$883K -$1.7M -85,545 -64%
SO
82
STRS Ohio
Ohio
$767K +$129K +6,500 +18%
Schroder Investment Management Group
83
Schroder Investment Management Group
United Kingdom
$761K +$84.5K +4,264 +11%
New York State Common Retirement Fund
84
New York State Common Retirement Fund
New York
$753K -$20 -1 -0%
RCAMU
85
Rothschild & Co Asset Management US
Connecticut
$738K -$35.9K -1,812 -4%
Comerica Bank
86
Comerica Bank
Texas
$728K -$27.6K -1,392 -4%
IIM
87
Ironwood Investment Management
Massachusetts
$706K -$23.6K -1,192 -3%
Royal Bank of Canada
88
Royal Bank of Canada
Ontario, Canada
$694K -$2.6M -131,245 -78%
CAM
89
ClariVest Asset Management
California
$685K +$7.93K +400 +1%
Nordea Investment Management
90
Nordea Investment Management
Sweden
$684K +$7.93K +400 +1%
MCM
91
Matarin Capital Management
New York
$671K +$40.3K +2,034 +6%
Federated Hermes
92
Federated Hermes
Pennsylvania
$639K -$13.3K -672 -2%
ERSOT
93
Employees Retirement System of Texas
Texas
$626K +$674K +34,000 New
AIMCA
94
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$598K – – –
AA
95
ALPS Advisors
Colorado
$582K +$41.4K +2,091 +7%
State of Tennessee, Department of Treasury
96
State of Tennessee, Department of Treasury
Tennessee
$576K – – –
Los Angeles Capital Management
97
Los Angeles Capital Management
California
$542K +$584K +29,458 New
ADEF
98
Adams Diversified Equity Fund
Maryland
$528K -$109K -5,500 -16%
Manulife (Manufacturers Life Insurance)
99
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$499K -$1.25K -63 -0.2%
O
100
OppenheimerFunds
New York
$488K +$178K +8,963 +51%
2 3
4
5 6

AMAG Hedge Fund Activity: Q2 2017 in Review

174 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q2 2017, worth a combined $802M — down 12% from $913M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of AMAG and 16 opened new positions — a net loss of 10 holders — while 58 trimmed existing stakes and 74 added.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $33.7M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $12.6M sold.

  • 174 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q2 2017, down from 185 in Q1 2017.
  • Funds reported $802M of AMAG Pharmaceuticals stock for Q2 2017, down 12% quarter-over-quarter.
  • 16 funds opened new AMAG Pharmaceuticals positions in Q2 2017 and 26 closed out, a net change of -10 holders.
  • The largest AMAG Pharmaceuticals buyer in Q2 2017 was Camber Capital Management, an estimated $33.7M added.
  • The largest AMAG Pharmaceuticals seller in Q2 2017 was Perceptive Advisors, an estimated $12.6M sold.

Based on aggregated 13F filings for Q2 2017.